HighRes, Novo Nordisk collaborate on robotics platform for drug discovery

By NS Healthcare Staff Writer

27 Jan 20

HighRes will integrate a multi-system robotics platform with advanced software control architecture for peptide and large molecule therapeutics…

PharmaceuticalsDrug delivery and formulation

Biotech start-up receives funding to make chemotherapy ‘smart drug’ that doesn’t cause side effects

By Dan Robinson

20 Jan 20

Chemotherapy is used to treat solid tumours, which account for more than 40% of cancers

PharmaceuticalsClinical trials

Pre-exposure Prophylaxis: A closer look at the treatment driving declining HIV transmission in the UK

By Jamie Bell

20 Jan 20

A number of health sector experts believe PrEP can reduce the likelihood of getting HIV by 99% when…

PharmaceuticalsClinical trials

Ubrogepant drug reduces pain and nausea in clinical trials of acute migraine patients

By Jamie Bell

04 Dec 19

The new drug differs from many established acute migraine treatments by lowering blood pressure, rather than raising it

PharmaceuticalsClinical trials

FDA approves REBLOZYL for treating anaemia in adults with beta thalassemia

By NS Healthcare Staff Writer

11 Nov 19

The BELIEVE trial has reached both primary and secondary end points and REBLOZYL has demonstrated reduced RBC transfusion…

PharmaceuticalsDrug delivery and formulation

Moberg Pharma and DongKoo join forces to commercialise MOB-015

By NS Healthcare Staff Writer

21 Oct 19

The previous phase 2 study of MOB-015 showed the delivery of high microgram levels of terbinafine into the…

PharmaceuticalsDrug delivery and formulation

Alexion secures FDA approval for ULTOMIRIS to treat aHUS

By NS Healthcare Staff Writer

21 Oct 19

FDA approval of ULTOMIRIS based on data from two global, single-arm open-label studies of ULTOMIRIS, separately in adults…

PharmaceuticalsDrug delivery and formulation

Type 2 diabetes treatment hopes boosted via protein linked to lower blood sugar levels

By Dan Robinson

24 Sep 19

Trinity College scientists claim to have identified a protein linked to lower blood sugar levels that may help…

PharmaceuticalsDrug delivery and formulation

Mylan launches generic version of Faslodex Injection to expand oncology portfolio

By NS Healthcare Staff Writer

18 Sep 19

The US Food and Drug Administration (FDA) has approved Mylan’s Abbreviated New Drug Application (ANDA) for the product

PharmaceuticalsDrug delivery and formulation

SunGen Pharma secures US FDA ANDA approval for Fosapreptant drug

By NS Healthcare Staff Writer

06 Sep 19

SunGen has opened its injectable division through the acquisition of a New Jersey-based pharmaceutical company

PharmaceuticalsDrug delivery and formulation